Skip to main content
Caplight Logo









Plantik Biosciences

Plantik Biosciences

Private
ParisHealthcare & Life Scienceshttps://www.plantik.bio/

Last Round

Accelerator

Nov 13, 2024

Total Funding Raised

$2.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Plantik Biosciences is an agritech company that develops climate-resilient crops using next-generation plant engineering and genome-editing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

genome editingagricultural biotechnologyCRISPRagtechclimate-resilient cropplant engineeringgene editingtrait developmentgenome analysis platformheat-tolerant cropplant breeding technologydark genome analysistrait licensingthermotolerant trait

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Plantik Biosciences Comparables

Compare Plantik Biosciences with similar companies based on industry and business-model similarity.

Plantik Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phytoform Labs
84%
Heritable Agriculture
82%
Resurrect bio
78%

Plantik Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 13, 2024
SeedFeb 6, 2024
GrantSep 13, 2022
AcceleratorJan 5, 2022
AcceleratorSep 10, 2020
Accelerator
Apr 8, 2020

Key People

Founding team and executive leadership

Ying Shao

Co-Founder & CEO

Founding Team

Plantik Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 96% MoM.

  • Feb 19, 2026

    Grew 50% QoQ from 6 to 9 employees.

Plantik Biosciences Filings

Explore SEC and related filing metadata, where available.

Plantik Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Plantik Biosciences's valuation, stock price, and market status.

Is Plantik Biosciences a public or private company?

Plantik Biosciences is a private company.

What is the current stock price of Plantik Biosciences?

Plantik Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Plantik Biosciences worth (valuation)?

Valuation information for Plantik Biosciences is not publicly available.

Can I buy Plantik Biosciences stock?

Plantik Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Plantik Biosciences's last funding round?

Plantik Biosciences's most recent funding round was Accelerator on November 13, 2024.

Who are the main investors in Plantik Biosciences?

Key investors in Plantik Biosciences include Future Food Fund.

Will Plantik Biosciences IPO soon?

No public IPO plans have been announced for Plantik Biosciences.

How can I track Plantik Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Plantik Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range11
Year Founded2019
Last FundingNov 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?